Stock Events

Regnum 

$0
5
-$0.01-98.31% Friday 20:32

Statistics

Day High
0.01
Day Low
0.01
52W High
0.8
52W Low
0.01
Volume
5,133
Avg. Volume
1,673
Mkt Cap
3.13M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30SepConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
-0
0
0
Expected EPS
N/A
Actual EPS
-0.0043

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RGMP. It's not an investment recommendation.

About

Software and Other Prerecorded Compact Disc, Tape, and Record Reproducing
Consumer Services
Manufacturing
Movies/Entertainment
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.
Show more...
CEO
Employees
1
ISIN
US75915R1068

Listings